Availability and costs of medicines for the treatment of tuberculosis in Europe

Archive ouverte

Günther, Gunar | Guglielmetti, Lorenzo | Leu, Claude | Lange, Christoph | van Leth, Frank | Khachatryan, Naira | Aroyan, Harut | Kabasakalyan, Eduard | Knappik, Michael | Skrahina, Alena | Klimuk, Dzmitry | Nikolenka, Alena | Muylle, Inge | Milanov, Vladimir | Velkovska, Desislava | Tarinska, Neli | Bachiyska, Elizabeta | Jankovic, Mateja | Pieridou, Despo | Adamide, Tonia | Nicolaou, Nicos | Vasakova, Martina | Sukholytka, Mariia | Kopeckà, Emilia | Folkvardsen, Dorte Bek | Svensson, Erik | Danilovits, Manfred | Kummik, Tiina | Vasankari, Tuula | Fréchet-Jachym, Mathilde | Nahmiash, Audrey | Togonidze, Tamar | Avaliani, Zaza | Kinkladze, Inga | Aspindzelashvili, Rusudan | Bichashvili, Teona | Losaberidze, Gulnazi | Merabishvili, Tsitsino | Kalsdorf, Barbara | Manika, Katerina | Tsiakitzis, Karyofyllis | Bakos, Agnes | Ægisdóttir, Tinna Rán | Michelsen, Guðrún Svanhvít | Karlsdóttir, Kristín | Mclaughlin, Anne-Marie | Fitzgibbon, Margaret | Chemtob, Daniel | Codecasa, Luigi | Ferrarese, Maurizio | Torri, Stefania | Gjocaj, Majlinda | Kuksa, Liga | Davidaviciene, Edita | Wirtz, Gil | Perrin, Monique | Asciak, Analita Pace | Chesov, Dumitri | de Lange, Wiel | Akkerman, Onno | Poposka, Biljana Ilievska | Mack, Ulrich | Jensenius, Mogens | Kvalvik, Lajla | Mengshoel, Anne Torunn | Kruczak, Katarzyna | Duarte, Raquel | Ribeiro, Nadine | Ibraim, Elmira | Kaluzhenina, Anna | Barkanova, Olga | Pesut, Dragica | Solovic, Ivan | Svetina, Petra | Souza-Galvão, Maria-Luiza De | Millet, Joan-Pau | Casas, Xavi | Vives, Montserrat | Bruchfeld, Judith | Dalemo, Paulina | Jonsson, Jerker | Aeschbacher, Katrin | Keller, Peter | Özkara, Seref | Tiberi, Simon | Chen, Christabelle | Terleeva, Yana | Dudnyk, Andrii

Edité par CCSD ; Elsevier for the European Society of Clinical Microbiology and Infectious Diseases -

International audience

Consulter en ligne

Suggestions

Du même auteur

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

Archive ouverte | van Leth, Frank | CCSD

International audience

National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey

Archive ouverte | Bothamley, Graham H. | CCSD

European-Respiratory-Society (ERS) International Congress, Madrid, SPAIN, SEP 28-OCT 02, 2019. International audience

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component

Archive ouverte | Guglielmetti, Lorenzo | CCSD

International audience. Rifapentine, a synthetic derivate of rifampicin which was developed in 1965, has interesting pharmacological properties, including a long terminal half-life (13 h, compared to 2-3 h for rifam...

Chargement des enrichissements...